Axa Ebit vs Tax Provision Analysis
EQH Stock | USD 40.40 0.08 0.20% |
Axa Equitable financial indicator trend analysis is way more than just evaluating Axa Equitable Holdings prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Axa Equitable Holdings is a good investment. Please check the relationship between Axa Equitable Ebit and its Tax Provision accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
Ebit vs Tax Provision
Ebit vs Tax Provision Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Axa Equitable Holdings Ebit account and Tax Provision. At this time, the significance of the direction appears to have weak relationship.
The correlation between Axa Equitable's Ebit and Tax Provision is 0.36. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Tax Provision in the same time period over historical financial statements of Axa Equitable Holdings, assuming nothing else is changed. The correlation between historical values of Axa Equitable's Ebit and Tax Provision is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of Axa Equitable Holdings are associated (or correlated) with its Tax Provision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Tax Provision has no effect on the direction of Ebit i.e., Axa Equitable's Ebit and Tax Provision go up and down completely randomly.
Correlation Coefficient | 0.36 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Ebit
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Most indicators from Axa Equitable's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Axa Equitable Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. As of now, Axa Equitable's Selling General Administrative is increasing as compared to previous years. The Axa Equitable's current Enterprise Value Over EBITDA is estimated to increase to 4.36, while Tax Provision is forecasted to increase to (718.2 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 6.6B | 10.4B | 6.3B | 7.5B | Total Revenue | 11.0B | 12.6B | 10.5B | 9.3B |
Axa Equitable fundamental ratios Correlations
Click cells to compare fundamentals
Axa Equitable Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Axa Equitable fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 493.6M | 450.4M | 417.4M | 379.9M | 351.6M | 391.5M | |
Total Assets | 249.9B | 282.3B | 292.3B | 252.7B | 266.8B | 271.6B | |
Short Long Term Debt Total | 4.1B | 4.1B | 5.1B | 5.2B | 4.7B | 4.0B | |
Other Current Liab | (2.1B) | (2.8B) | (2.8B) | (714M) | 2.2B | 2.3B | |
Total Current Liabilities | 2.1B | 2.8B | 2.8B | 3.0B | 5.1B | 2.8B | |
Total Stockholder Equity | 13.5B | 15.6B | 11.5B | 1.4B | 2.6B | 2.5B | |
Other Liab | 215.6B | 251.1B | 272.3B | 232.4B | 267.3B | 237.9B | |
Net Tangible Assets | 7.7B | 11.0B | 5.2B | (3.4B) | (3.0B) | (2.9B) | |
Net Debt | (294M) | (2.1B) | (66M) | 950M | (4.5B) | (4.2B) | |
Retained Earnings | 11.8B | 10.7B | 8.9B | 9.8B | 10.2B | 8.8B | |
Accounts Payable | 2.1B | 2.8B | 2.7B | 2.2B | 2.7B | 2.5B | |
Cash | 4.4B | 6.2B | 5.2B | 4.3B | 9.1B | 6.2B | |
Non Current Assets Total | 79.5B | 93.8B | 88.2B | 74.2B | 243.3B | 255.5B | |
Non Currrent Assets Other | (79.5B) | (93.8B) | (88.2B) | (1.2B) | 227.7B | 239.0B | |
Other Assets | 159.4B | 93.5B | 181.6B | 81.1B | 147.3B | 130.0B | |
Long Term Debt | 6.4B | 4.1B | 5.0B | 4.5B | 5.4B | 4.6B | |
Cash And Short Term Investments | 4.4B | 88.2B | 5.2B | 4.3B | 75.3B | 79.0B | |
Net Receivables | 6.6B | 6.8B | 17.3B | 11.6B | 12.2B | 10.2B | |
Good Will | 4.6B | 4.6B | 4.6B | 5.1B | 4.6B | 3.8B | |
Short Term Investments | 66.3B | 82.0B | 79.9B | 64.9B | 1.5B | 1.4B | |
Long Term Debt Total | 6.4B | 4.1B | 3.9B | 3.3B | 3.0B | 4.4B | |
Liabilities And Stockholders Equity | 249.9B | 282.3B | 292.3B | 252.7B | 266.8B | 271.6B | |
Non Current Liabilities Total | 4.7B | 4.9B | 5.0B | 3.3B | 256.5B | 269.3B | |
Capital Surpluse | 1.9B | 2.0B | 1.9B | 2.3B | 2.6B | 1.8B | |
Other Current Assets | 14.2B | 21.3B | 27.6B | 29.7B | 23.5B | 18.8B | |
Other Stockholder Equity | 88M | (260M) | (931M) | (998M) | (1.4B) | (1.3B) | |
Total Liab | 234.4B | 265.0B | 278.7B | 249.1B | 261.6B | 257.4B | |
Deferred Long Term Liab | 5.9B | 749M | 5.5B | 8.2B | 7.4B | 4.5B | |
Long Term Investments | 74.7B | 109.1B | 105.1B | 93.1B | 75.2B | 84.7B | |
Short Long Term Debt | 2.9B | 546M | 92M | 759M | 254M | 241.3M | |
Total Current Assets | 11.0B | 95.0B | 22.5B | 97.4B | 23.5B | 42.2B | |
Accumulated Other Comprehensive Income | 840M | 3.9B | 2.0B | (9.0B) | (7.8B) | (7.4B) | |
Short Term Debt | 4.1B | 4.1B | 92M | 759M | 254M | 241.3M | |
Intangible Assets | 4.8B | 4.7B | 4.7B | 5.5B | 5.4B | 4.5B | |
Cash And Equivalents | 4.4B | 6.2B | 5.2B | 4.3B | 3.9B | 4.0B | |
Net Invested Capital | 16.9B | 18.7B | 15.1B | 5.3B | 6.7B | 11.6B | |
Warrants | 365M | 143M | 468M | 455M | 523.3M | 356.0M | |
Noncontrolling Interest In Consolidated Entity | 1.6B | 1.6B | 1.6B | 1.7B | 2.0B | 1.8B | |
Retained Earnings Total Equity | 11.8B | 10.7B | 8.9B | 9.9B | 8.9B | 8.9B |
Pair Trading with Axa Equitable
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axa Equitable position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axa Equitable will appreciate offsetting losses from the drop in the long position's value.Moving together with Axa Stock
0.69 | FIHL | Fidelis Insurance Report 28th of June 2024 | PairCorr |
0.9 | AEG | Aegon NV ADR | PairCorr |
0.85 | AIG | American International | PairCorr |
Moving against Axa Stock
0.75 | GSHD | Goosehead Insurance | PairCorr |
0.46 | ACGLO | Arch Capital Group | PairCorr |
The ability to find closely correlated positions to Axa Equitable could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axa Equitable when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axa Equitable - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axa Equitable Holdings to buy it.
The correlation of Axa Equitable is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axa Equitable moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axa Equitable Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axa Equitable can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Axa Stock analysis
When running Axa Equitable's price analysis, check to measure Axa Equitable's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axa Equitable is operating at the current time. Most of Axa Equitable's value examination focuses on studying past and present price action to predict the probability of Axa Equitable's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axa Equitable's price. Additionally, you may evaluate how the addition of Axa Equitable to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Axa Equitable's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axa Equitable. If investors know Axa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axa Equitable listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Dividend Share 0.9 | Earnings Share 3.33 | Revenue Per Share 30.362 | Quarterly Revenue Growth (0.05) |
The market value of Axa Equitable Holdings is measured differently than its book value, which is the value of Axa that is recorded on the company's balance sheet. Investors also form their own opinion of Axa Equitable's value that differs from its market value or its book value, called intrinsic value, which is Axa Equitable's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axa Equitable's market value can be influenced by many factors that don't directly affect Axa Equitable's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axa Equitable's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axa Equitable is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axa Equitable's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.